149 related articles for article (PubMed ID: 34369050)
1. Granulocyte and monocyte adsorptive apheresis for pyoderma gangrenosum.
Higashi Y; Ibusuki A; Baba N; Hatanaka M; Tada KI; Kanekura T
Ther Apher Dial; 2022 Apr; 26(2):450-455. PubMed ID: 34369050
[TBL] [Abstract][Full Text] [Related]
2. Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroids.
Kawai M; Kawanami C; Fukuda A; Seno H
Clin J Gastroenterol; 2021 Oct; 14(5):1561-1566. PubMed ID: 34101129
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis.
Russo I; Miotto S; Colpo A; Marson P; Tison T; Ferrazzi A; Alaibac M
Int Wound J; 2017 Feb; 14(1):282-284. PubMed ID: 27790848
[TBL] [Abstract][Full Text] [Related]
4. Pyoderma gangrenosum in an ulcerative colitis patient during treatment with vedolizumab responded favorably to adsorptive granulocyte and monocyte apheresis.
Shibuya T; Haga K; Saeki M; Haraikawa M; Tsuchihashi H; Okahara K; Nomura O; Fukushima H; Murakami T; Ishikawa D; Ikeda S; Nagahara A
J Clin Apher; 2020 Sep; 35(5):488-492. PubMed ID: 32767842
[TBL] [Abstract][Full Text] [Related]
5. Pyoderma Gangrenosum with Ulcerative Colitis Successfully Treated by the Combination of Granulocyte and Monocyte Adsorption Apheresis and Corticosteroids.
Ohno M; Koyama S; Ohara M; Shimamoto K; Kobayashi Y; Nakamura F; Mitsuru K; Andoh A
Intern Med; 2016; 55(1):25-30. PubMed ID: 26726081
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum.
Seishima M; Mizutani Y; Shibuya Y; Nagasawa C; Aoki T
Ther Apher Dial; 2007 Jun; 11(3):177-82. PubMed ID: 17497998
[TBL] [Abstract][Full Text] [Related]
7. Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis.
Kanekura T; Kawahara K; Maruyama I; Kanzaki T
Ther Apher Dial; 2005 Aug; 9(4):292-6. PubMed ID: 16076369
[TBL] [Abstract][Full Text] [Related]
8. Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis.
Kawakami T; Yamazaki M; Soma Y
Am J Gastroenterol; 2009 Sep; 104(9):2363-4. PubMed ID: 19727102
[No Abstract] [Full Text] [Related]
9. Pyoderma gangrenosum associated with ulcerative colitis: A recalcitrant case responded to adalimumab with granulocyte and monocyte adsorption apheresis.
Isami Y; Kawase Y; Kondo A; Akita W; Yasuda K; Matsutani T; Mitsui H
J Dermatol; 2020 May; 47(5):e213-e215. PubMed ID: 32162361
[No Abstract] [Full Text] [Related]
10. Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study.
Ishiguro Y; Ohmori T; Umemura K; Iizuka M
Ther Apher Dial; 2021 Aug; 25(4):502-512. PubMed ID: 33029920
[TBL] [Abstract][Full Text] [Related]
11. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
12. Retrospective Single Center Study of Granulocyte Monocyte Adsorption Apheresis Treatment in Inflammatory Bowel Disease.
Edfors K; Ståhlberg D; Söderman C
Ther Apher Dial; 2016 Feb; 20(1):79-85. PubMed ID: 26841133
[TBL] [Abstract][Full Text] [Related]
13. Targeting neutrophils in inflammatory bowel disease: revisiting the role of adsorptive granulocyte and monocyte apheresis.
Bamias G; Zampeli E; Domènech E
Expert Rev Gastroenterol Hepatol; 2022 Aug; 16(8):721-735. PubMed ID: 35833363
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome with granulocyte and monocyte adsorption apheresis.
Hatanaka M; Fujii K; Kanekura T
J Dermatol; 2021 Aug; 48(8):e376-e377. PubMed ID: 33991008
[No Abstract] [Full Text] [Related]
15. Clinical and immunological effects of adsorptive myeloid lineage leukocyte apheresis in patients with immune disorders.
Kanekura T
J Dermatol; 2018 Aug; 45(8):943-950. PubMed ID: 29782055
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Usefulness of New Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis in Active Ulcerative Colitis Patients Without Corticosteroids and Biologics.
Shimazu K; Fukuchi T; Kim I; Noguchi Y; Iwata M; Koyama S; Ubukata S; Tanaka A
Ther Apher Dial; 2016 Aug; 20(4):383-9. PubMed ID: 27523079
[TBL] [Abstract][Full Text] [Related]
17. Pyoderma Gangrenosum, Acne and Suppurative Hidradenitis Syndrome Treated with Granulocyte and Monocyte Adsorption Apheresis.
Mizutani Y; Okano T; Takahashi T; Ohnishi H; Ohara O; Sano A; Seishima M
Acta Derm Venereol; 2017 Feb; 97(2):275-276. PubMed ID: 27384061
[No Abstract] [Full Text] [Related]
18. Intensive granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis.
Mizutani Y; Fujii K; Kawamura M; Inoue M; Mizutani YH; Matsuyama K; Doi T; Nagaya S; Seishima M
J Dermatol; 2020 Nov; 47(11):1326-1329. PubMed ID: 32860246
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte apheresis for pouchitis with arthritis and pyoderma gangrenosum after restorative proctocolectomy for ulcerative colitis: a case report.
Yanaru-Fujisawa R; Matsumoto T; Nakamura S; Kochi S; Iida M; Kohda F; Hirahashi M; Yao T; Mibu R
Inflamm Bowel Dis; 2005 Aug; 11(8):780-1. PubMed ID: 16043996
[No Abstract] [Full Text] [Related]
[Next] [New Search]
